1 / 15

Atherosclerosis Treatment Drugs Market Analysis (2018 - 2026)

Read here the market research report on the u201cAtherosclerosis Treatment Drugs Market" published by CMI Team

kunalbhuta
Download Presentation

Atherosclerosis Treatment Drugs Market Analysis (2018 - 2026)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. ATHEROSCLEROSIS TREATMENT DRUGS MARKET ANALYSIS (2018 - 2026) • Atherosclerosis Treatment Drugs Market, by Drug Type (Cholesterol medications, Beta Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel blocker, Diuretics, Antiplatelet, and Other Medications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

  3. Atherosclerosis is characterized by the narrowing and hardening of the arteries. In this condition, arteries become blocked by fatty substances, such as cholesterol. These substances are called as plaques or atheroma. The risks of atherosclerosis increase with age. The deposition of plaque tends to narrow the arterial canal, which result in the limited flow of blood and oxygen through it. Atherosclerosis commences with damage to the endothelium of arteries leading to the formation of plaque. This condition is dangerous for the vital organs such as heart and brain. The risk associated with atherosclerosis includes serious cardiovascular and brain diseases. Collectively, these conditions are more common for cardiovascular diseases (CVD) including coronary heart disease, angina pectoris, and transitory ischemia. Other risks for atherosclerosis are carotid artery disease, kidney disease, and peripheral artery disease.

  4. Atherosclerosis Treatment Drugs Market - Driver • Increasing number of pipeline studies and rising involvement of key players for developing the treatment options for atherosclerosis are expected to propel atherosclerosis treatment drugs market growth. For Instance, in November 13, 2018, Bayer in collaboration with Janssen, LP started the clinical study for Rivaroxaban and Acetylsalicylic Acid to build up the insights in treatment patterns and to study results of Rivaroxaban (Xarelto) in combination with acetylsalicylic acid (xatoa) prescribed to patients with atherosclerosis. The study is estimated to complete in August 2021.

  5. Moreover, technological advancement in the atherosclerosis treatment procedures is expected to boost the atherosclerosis treatments drug market growth. For instance, in May 2017, Researchers at Ben-Gurion University (BGU) and the Sheba Medical Center developed Nano polymer therapy, a new therapy for the treatment of atherosclerosis. It prevents heart failure with a new biomedical polymer (E-selectin-targeting polymer) that reduces arterial plaque and inflammation in the cardiovascular system. E-selectin-targeting polymer helps to reduce existing plaque and impedes the further plaque formation. It also prevents arterial thrombosis, ischemia, myocardial infarction, and strokes.

  6. Market Restraints • Lack of awareness about industrial work safety is expected to restrain growth of the global strobe and beacons market over the forecast period • The negligence about installation of warning systems and lack of awareness about the industrial work safety in many emerging economies is expected to hamper the growth of the global strobe and beacons market over the forecast period. For instance, according to the International Labor Organization (ILO), and United Nations Agency, in 2017, there were around 380,500 total global fatal industrial accidents, which is 8% increase from the previous year.

  7. Atherosclerosis Treatment Drugs Market- Restraints • However, the side effects associated with atherosclerosis drugs and limited efficacy of the drugs is expected to hamper atherosclerosis market growth. For instance, in November 2016, The Lancet led by Rory Collins, provided an evidence on statin therapy and the methodological limitations. As per data, statins are associated with increased incidence of diabetes and hemorrhagic stroke. Statins tends to increase the risk of type 2 diabetes in a dose-dependent mode.

  8. Atherosclerosis Treatment Drugs Market- Regional Analysis • On the basis of region, the global atherosclerosis treatment drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. • Geographically, North America is expected to gain significant market share over the forecast period, owing to increasing incidences of atherosclerotic condition among the population in this region. For instance, in November 2016, as per data provided by the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), there were more than 15.5 million Americans who had coronary artery disease and it is expected that for every 42 seconds an American will experience the onset of a myocardial infarction.

  9. Furthermore, Asia Pacific is expected to witness significant growth in the market, owing to expansion of major key players in this region. For instance, in October 2017, GSK opened its new regional headquarters for Asia in Singapore. The GSK’s purpose for building headquarters is to support the pharmaceutical, vaccines, and consumer healthcare businesses across multiple regions in Asia Pacific. • Key players operating in the Atherosclerosis treatment drugs market include GlaxoSmithKline plc. Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Isis Pharmaceuticals, Inc., Anthera Pharmaceuticals, Novartis AG, Sanofi, Johnson and Johnson, Bayer AG, The Medicine Company, and Cardium Therapeutics. 

  10. Atherosclerosis Treatment Drugs Market- Taxonomy • By Drugs Type • Cholesterol medications • Beta Blockers • Angiotensin-converting enzyme (ACE) Inhibitors • Calcium Channel blocker • Diuretics • Antiplatelet • Other Medications • By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies

  11. By Region • North America • Europe • Asia Pacific • Latin America • Middle East • Africa

  12. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference:https://www.coherentmarketinsights.com/ongoing-insight/atherosclerosis-treatment-drugs-market-2430

  13. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  14. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related